Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      FDA approves new combination treatment for acute myeloid leukemia

      FDA approves new combination treatment for acute myeloid leukemia

      supriya kashyap kashyap30 April 2017 10:15 AM IST
      The U.S. Food and Drug Administration approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia...
      Siemens Healthineers announces launch of first fully automated lab

      Siemens Healthineers announces launch of first fully automated lab

      supriya kashyap kashyap30 April 2017 10:10 AM IST
      New Delhi : Siemens Healthineers has announced successful installation of India’s first fully automated Aptio Automation track with multi discipline...
      Aurobindo Pharma completes acquisition of Portugal’s Generis

      Aurobindo Pharma completes acquisition of Portugal’s Generis

      supriya kashyap kashyap29 April 2017 12:48 PM IST
      Hyderabad : Aurobindo Pharma Ltd has completed the acquisition of Generis Farmaceutica S.A. in Portugal.In January this year, Hyderabad-based...
      Dr Reddys gets 11 observations from USFDA for Hyderabad plant

      Dr Reddy's gets 11 observations from USFDA for Hyderabad plant

      supriya kashyap kashyap29 April 2017 11:57 AM IST
      New Delhi : Drug major Dr Reddy's Laboratories said the US health regulator has issued 11 observations after inspecting its manufacturing plant in...
      Cipla plea in High Court against change in price of asthma drugs

      Cipla plea in High Court against change in price of asthma drugs

      supriya kashyap kashyap29 April 2017 11:34 AM IST
      New Delhi : The Delhi High Court sought the Centre's response on a plea by pharma major Cipla against a notification capping the prices of the...
      Vancomycin Etoposide Noradrenaline Digoxin and other comes under price control : NPPA

      Vancomycin Etoposide Noradrenaline Digoxin and other comes under price control : NPPA

      supriya kashyap kashyap29 April 2017 11:29 AM IST
      New Delhi : The National Pharmaceutical Pricing Authority (NPPA) has fixed ceiling prices of 15 more drugs, including those used for treatment of...
      Tymlos New osteoporosis drug gets FDA approval : Radius Healths

      Tymlos New osteoporosis drug gets FDA approval : Radius Health's

      supriya kashyap kashyap29 April 2017 10:51 AM IST
      The U.S. Food and Drug Administration approved Radius Health Inc's drug to treat osteoporosis in postmenopausal women at high risk of fracture or...
      Find how Healthcare IT fared in funding this year : Mercom Capital Group Report

      Find how Healthcare IT fared in funding this year : Mercom Capital Group Report

      supriya kashyap kashyap28 April 2017 10:21 AM IST
      New Delhi : Mercom Capital Group, llc, a global communications and research firm, released its report on funding and mergers and acquisitions...
      Woman fined Rs 50K for submitting forged documents for claim

      Woman fined Rs 50K for submitting forged documents for claim

      supriya kashyap kashyap26 April 2017 10:21 AM IST
      New Delhi : The apex consumer commission has imposed a fine of Rs 50,000 on a woman for submitting forged documents for claiming insurance.The...
      AbbVie cancer drug fails two late-stage trials

      AbbVie cancer drug fails two late-stage trials

      supriya kashyap kashyap23 April 2017 12:54 PM IST
      AbbVie Inc said that its experimental cancer drug, veliparib, failed to meet the main goals of two late-stage studies.The trials evaluated the effect...
      Max Bupa collaborates with GOQii, Swiss Re to promote holistic healing

      Max Bupa collaborates with GOQii, Swiss Re to promote holistic healing

      supriya kashyap kashyap23 April 2017 12:45 PM IST
      New Delhi : Health care and insurance expert Max Bupa Health Insurance has announced an exclusive three-way tie up with GOQii, a fitness technology...
      Fight against neglected tropical diseases needs Big Pharma push: WHO

      Fight against neglected tropical diseases needs Big Pharma push: WHO

      supriya kashyap kashyap23 April 2017 11:54 AM IST
      Geneva : Progress has been made in tackling diseases that blind, disable and disfigure millions of poor in tropical areas each year, but drug...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok